ArticleCancer research communications2024

EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas.

Tanner J DuCote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.